Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cancer, Future Science OA, Future Science
Lay abstract Cancer antigen 72–4 is a tumor marker for ovarian
cancer. It can be measured in blood samples of patients to monitor the
disease. We compared an established method of measurement with a newly
designed one (DRG TM-CA 72–4 ELISA) and found that the newer one
produced reliable results. Therefore, the DRG TM-CA 72–4 ELISA could be
an option for the measurement of cancer antigen 72–4 in ovarian cancer
patients.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.